The DOI matches its Crossref record; 193 of the 198 references it cites were found in a registry or an index.
Cancer-associated fibroblasts in tumor microenvironment–Accomplices in tumor malignancy
Abstract
There is much cellular heterogeneity in the tumor microenvironment. The tumor epithelia and stromal cells co-evolve, and this reciprocal relationship dictates almost every step of cancer development and progression. Despite this, many anticancer therapies are designed around druggable features of tumor epithelia, ignoring the supportive role of stromal cells. Cancer-associated fibroblasts (CAFs) are the dominant cell type within the reactive stroma of many tumor types. Numerous previous studies have highlighted a pro-tumorigenic role for CAFs via secretion of various growth factors, cytokines, chemokines, and the degradation of extracellular matrix. Recent works showed that CAFs secrete H 2 O 2 to effect stromal-mediated field cancerization, transform primary epithelial cells, and aggravate cancer cell aggressiveness, in addition to inflammatory and mitogenic factors. Molecular characterization of CAFs also underscores the importance of Notch and specific nuclear receptor signaling in the activation of CAFs. This review consolidates recent findings of CAFs and highlights areas for future investigations.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Secondly, metabolic disorders including cardiometabolic syndrome (CMS), diabetes, cardiovascular disease (CVD), and cancer are common comorbidities of SO (54, 55).”
From Diabetes and Sarcopenic Obesity: Pathogenesis, Diagnosis, and Treatments (2020) · cites this paper as [55]
Citations
Cites
Microenvironmental regulation of tumor progression and metastasis
Quail, D. F., & Joyce, J. A. (2013) · Nature Medicine · doi:10.1038/nm.3394 · Cited by 7,994
The distribution of secondary growths in cancer of the breast.
Paget, S. (1889) · The Lancet · doi:10.1016/s0140-6736(00)49915-0 · Cited by 5,277
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
Hanahan, D., & Coussens, L. M. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.022 · Cited by 4,632
The biology and function of fibroblasts in cancer
Kalluri, R. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.73 · Cited by 4,366
Orimo, A., Gupta, P. B., Sgroi, D. C., Arenzana-Seisdedos, F., Delaunay, T., Naeem, R., Carey, V. J., Richardson, A. L., & Weinberg, R. A. (2005) · Cell · doi:10.1016/j.cell.2005.02.034 · Cited by 3,759
Slaughter, D. P., Southwick, H. W., & Smejkal, W. (1953) · Cancer · doi:10.1002/1097-0142(195309)6:5 · Cited by 3,558
Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability
Colotta, F., Allavena, P., Sica, A., Garlanda, C., & Mantovani, A. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp127 · Cited by 2,960
Özdemir, B. C., Pentcheva-Hoang, T., Carstens, J. L., Zheng, X., Wu, C.-C., Simpson, T. R., Laklai, H., Sugimoto, H., Kahlert, C., Novitskiy, S. V., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.04.005 · Cited by 2,681
Feig, C., Jones, J. O., Kraman, M., Wells, R. J. B., Deonarine, A., Chan, D. S., Connell, C. M., Roberts, E. W., Zhao, Q., Caballero, O. L., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1320318110 · Cited by 2,100
Pankov, R. G., & Yamada, K. M. (2002) · Journal of Cell Science · doi:10.1242/jcs.00059 · Cited by 2,055
Flagged first, then by citations
5 of the 198 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 301–335 of 335
Zhou, X., Wang, S., Xu, X., Meng, X., Zhang, H., Zhang, A., Song, Y., Zhu, H., Yang, Z., & Li, N. (2021) · Research Square · doi:10.21203/rs.3.rs-455463/v1
The Tumor Environment: Cholangiocarcinoma-Associated Fibroblasts and Beyond
Moncsek, A., & Mertens, J. C. (2021) · Springer eBooks · doi:10.1007/978-3-030-70936-5_24
Characteristics and therapy of advanced cancer diseases
Taghizadeh, H. (2021)
Kim, D., & Moon, S. (2021) · Journal of dental hygiene science · doi:10.17135/jdhs.2021.21.4.227
Pan-cancer analysis of BLM as a prognostic and immunological marker in human tumorsPreprint
Hou, Y., Lan, C., Ren, D., & Wang, X. (2021) · Research Square · doi:10.21203/rs.3.rs-837352/v1
Tumor-asszociált miofibroblasztok genetikai, epigenetikai, transzkripciós és funkcionális jellemzői
Huliák, I. (2021) · SZTE Repository of Dissertations (University of Szeged) · doi:10.14232/phd.10787
Lohmueller, J. J., & Cascio, S. (2019) · Cellular Immunology · doi:10.1016/j.cellimm.2019.103967
Modeling the Tumor Microenvironment in Patient-Derived Xenografts: Challenges and Opportunities
Kleinmanns, K., Gjerde, C. H., Langer, A., Fosse, V., de Jalón, E. G., Leitch, C., Popa, M. L., Gélébart, P., & McCormack, E. (2022) · Springer eBooks · doi:10.1007/978-3-030-98950-7_19
Liu, J., Xiao, L., Luo, S., Liu, J., Tang, Y., & Zhou, B. (2023) · Research Square · doi:10.21203/rs.3.rs-2937192/v1
Zhao, S., Yin, S., Zhang, Q., Zafereo, M., Gross, N. D., Li, G., Liu, J., & Sun, P. (2023) · SSRN Electronic Journal · doi:10.2139/ssrn.4476200
Assessing the awareness regarding cervical cancer in Vidarbha: A Cross-Sectional Study
joshi, D., & Mude, G. S. (2023) · F1000Research · doi:10.12688/f1000research.135180.1
Mechanoregulation of angiopoietin-like 4 in epithelial-mesenchymal transition and cancer metastasis
Liao, Z. (2023) · DR-NTU (Nanyang Technological University) · doi:10.32657/10356/173585
Self-citationLi, S., Pan, Y., Hao, X., & Liu, X. (2024) · Research Square · doi:10.21203/rs.3.rs-4124427/v1
Liu, L., Liu, Z., Fan, L., Yao, Z., Hu, J., Hou, Y., Li, Y., Ding, Y., Kuang, Y., Chen, K., et al. (2024) · eLife · doi:10.7554/elife.95326.1
Li, T., Liu, Y., Dai, M., Zhao, X., Han, J., Zhang, Z., Jing, F., Tian, W., Wang, J., Zhao, X., et al. (2024) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2024.0026
Zhang, T., Hu, Y., Li, H., Wang, J., Xu, Q., Xu, Y., & Sun, H. (2025) · Acta Radiologica · doi:10.1177/02841851251316435
Guo, W., Zhao, X., Huang, X., Zhang, R., Wang, Y., He, X., Ma, X., Hao, Y., Geng, S., Pan, S., et al. (2025) · Journal of Molecular Histology · doi:10.1007/s10735-025-10452-0
Liu, L., Liu, Z., Fan, L., Yao, Z., Hu, J., Hou, Y., Li, Y., Ding, Y., Kuang, Y., Chen, K., et al. (2025) · eLife · doi:10.7554/elife.95326.2
Chang, X., Tan, Q., Xu, J., Wu, X., Wang, Y., Zhang, Y., Zhang, H., Liu, H., & Yan, L. (2024) · Figshare · doi:10.6084/m9.figshare.26643460
Chang, X., Tan, Q., Xu, J., Wu, X., Wang, Y., Zhang, Y., Zhang, H., Liu, H., & Yan, L. (2024) · Figshare · doi:10.6084/m9.figshare.26643457
Pérez-Miles, F., Gabriel, R., Miglio, L., Bonaldo, A., Gallon, R., Jiménez, J. J., & Bertani, R. (2008) · INFM-OAR (INFN Catania) · doi:10.5281/zenodo.184594
Shi, Y., Yan, J.-H., Liu, W., & Deng, J. (2023) · Figshare · doi:10.6084/m9.figshare.22775903
Targeting lipid metabolism in CAFs: A therapeutic opportunity in solid tumors
Ai, Q., Bin, W. H., Zhang, W., & Xu, X.-Y. (2026) · Translational research · doi:10.1016/j.trsl.2026.02.003
Ma, Y., Zhang, N., Wu, S., He, J., Jiang, Y., Qin, M., Feng, H., Li, W., & Hou, Y. (2026) · Nanoscale · doi:10.1039/d5nr05495h
Tumor microenvironment-induced epigenetic reprogramming of Tregs and its impact on immunotherapy
Li, W., & Tong, J. (2026) · Frontiers in Genetics · doi:10.3389/fgene.2026.1787421
Le rôle de deux alarmines extracellulaires, HMGB1 et l’ATP, dans le cadre du cancer colorectal
Dillard, C. (2021) · theses.fr (ABES) · doi:10.70675/51029938z640az4398za0f8z6a69fb660b30
Nanoparticles for autoimmune diseases: advancing diagnostics and therapeutic solutions
Ong, E. X. N., Ng, C. Y. J., Cao, L.-L., Li, X., Li, P. P., Tan, N. S., Liao, Z., & Zhao, Y. (2026) · Acta Pharmacologica Sinica · doi:10.1038/s41401-026-01794-w · Cited by 2
Self-citationZhang, Y., Zhang, Y., You, J., Lu, Z., & Zhao, T. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1786697
Allam, E. K., Metwaly, H., Megahed, E., Shakweer, M. M., & Youssef, H. M. K. (2026) · Applied immunohistochemistry & molecular morphology · doi:10.1097/pai.0000000000001326
Qiao, K., Huang, Y., Chua, D., Qu, J., Liao, Q., Wang, G., Tan, N. S., Liao, S., Li, L., & Zhang, G. (2026) · Molecular Therapy Oncology · doi:10.1016/j.omton.2026.201251
Self-citationSadeghpour, S., Aghaee, A., Doostparast, A., Borujerdi, N. R., Divband, G., Raeisi, N., Roeder, F., Jung, T., Pirich, C., Soltani, S., et al. (2026) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2026.06.002
Wang, X.-Y., & Ren, G. (2026) · World Chinese Journal of Digestology · doi:10.11569/wcjd.v34.i6.433
Redox-responsive nanocarriers for biomedical application
Abishek, K. G., Gopinath, P., Ramesh, S., Gupta, G., Sahebkar, A., Kesharwani, P., & Dandela, R. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-33641-6.00023-3
Zinc homeostasis in cancer: From dynamic regulation to therapeutic potential
Pan, X., Ma, Y., Zou, D., Yan, Y., Hu, X., Miao, Y., Li, Y., Wu, H., Wei, M., & Tang, Y. (2026) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2026.101765
Metadata
- Authors
- Liao, Z., Tan, Z. W., Zhu, P., & Tan, N. S.
- Affiliations
- Nanyang Technological University (SG)
- Agency for Science, Technology and Research (SG)
- Corresponding author
- Tan, Zhen Wei
- Tan, Nguan Soon
- Venue
- Cellular Immunology
- Publisher
- Elsevier BV
- Published
- 2019-09
- Volume
- 343
- Pages
- 103729
- ISSN
- 0008-8749 (ISSN-L)
- OpenAlex
- W2789705845
- Cited by
- 335
- References
- 198
- Citations by year
- 2026: 18 · 2025: 33 · 2024: 49 · 2023: 61 · 2022: 55 · 2021: 52 · 2020: 28 · 2019: 24
- FWCI
- 3.06
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Cellular Immunology (publishedVersion)
- PubMed (publishedVersion)
- DR-NTU (Nanyang Technological University) (submittedVersion)
- Funders
- Ministry of Education - Singapore (MOE2012-T1-001-036, MOE2014-T2-1-012, RG134/15)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Keywords
- cancer-associated fibroblasts, tumor microenvironment, tumor stroma, reactive stroma, tumor progression, extracellular matrix degradation, hydrogen peroxide, field cancerization, epithelial transformation, Notch signaling, nuclear receptor signaling, tumor inflammation, stromal-epithelial crosstalk
- MeSH terms
- Cancer-Associated Fibroblasts, Animals, Humans, Neoplasms, Tumor Microenvironment, Carcinogenesis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review